Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152)
Griffin, Matthew D. , Hong, David K. , Holman, Philmore O., Lee, Kyung‐Mi , Whitters, Matthew J., O’Herrin, Sean M., Collins, Mary , Segal, David M., Kranz, David M. , Fallarino, Francesca , Gajewski, Thomas Frank , Bluestone, Jeffrey A. , Griffin, Matthew D

The Journal of Immunology | April 21, 2014 | Volume: 164 | Issue: 9 | Pages: 4433-4442

10.4049/jimmunol.164.9.4433 | PMID 10779742 Get It

Abstract CTLA-4 (CD152) engagement can down-regulate T cell activation and promote the induction of immune tolerance. However, the strategy of attenuating T cell activation by engaging CTLA-4 has been limited by sharing of its natural ligands with the costimulatory protein CD28. In the present study, a CTLA-4-specific single-chain Ab (scFv) was developed and expressed on the cell surface to promote selective engagement of this regulatory molecule. Transfectants expressing anti-CTLA-4 scFv at their surface bound soluble CTLA-4 but not soluble CD28. Coexpression of anti-CTLA-4 scFv with anti-CD3ε and anti-CD28 scFvs on artificial APCs reduced the proliferation and IL-2 production by resting and preactivated bulk T cells as well as CD4+ and CD8+ T cell subsets. Importantly, expression of anti-CTLA-4 scFv on the same cell surface as the TCR ligand was essential for the inhibitory effects of CTLA-4-specific ligation. CTLA-4-mediated inhibition of tyrosine phosphorylation of components of the proximal TCR signaling apparatus was similarly dependent on coexpression of TCR and CTLA-4 ligands on the same surface. These findings support a predominant role for CTLA-4 function in the modification of the proximal TCR signal. Using T cells from DO11.10 and 2C TCR transgenic mice, negative regulatory effects of selective CTLA-4 ligation were also demonstrated during the stimulation of Ag-specific CD4+ and CD8+ T cells by MHC/peptide complexes. Together these studies demonstrate that selective ligation of CTLA-4 using a membrane-bound scFv results in attenuated T cell responses only when coengaged with the TCR during T cell/APC interaction and define an approach to harnessing the immunomodulatory potential of CTLA-4-specific ligation.
Monomeric Class I Molecules Mediate TCR/CD3ε/CD8 Interaction on the Surface of T Cells
Block, Matthew S. , Johnson, Aaron J. , Mendez-Fernandez, Yanice , Pease, Larry R. , Johnson, Aaron J.

The Journal of Immunology | April 21, 2014 | Volume: 167 | Issue: 2 | Pages: 821-826

10.4049/jimmunol.167.2.821 | PMID 11441088 Get It

Abstract Both CD8 and the TCR bind to MHC class I molecules during physiologic T cell activation. It has been shown that for optimal T cell activation to occur, CD8 must be able to bind the same class I molecule that is bound by the TCR. However, no direct evidence for the class I-dependent association of CD8 and the TCR has been demonstrated. Using fluorescence resonance energy transfer, we show directly that a single class I molecule causes TCR/CD8 interaction by serving as a docking molecule for both CD8 and the TCR. Furthermore, we show that CD3ε is brought into close proximity with CD8 upon TCR/CD8 association. These interactions are not dependent on the phosphorylation events characteristic of T cell activation. Thus, MHC class I molecules, by binding to both CD8 and the TCR, mediate the reorganization of T cell membrane components to promote cellular activation.
Identification of New Epitopes from Four Different Tumor-Associated Antigens: Recognition of Naturally Processed Epitopes Correlates with HLA-A∗0201-Binding Affinity
Keogh, Elissa , Fikes, John, Southwood, Scott, Chesnut, Robert W., Celis, Esteban , Sette, Alessandro

The Journal of Immunology | April 21, 2014 | Volume: 167 | Issue: 2 | Pages: 787-796

10.4049/jimmunol.167.2.787 | PMID 11441084 Get It

Abstract Forty-two wild-type and analogue peptides derived from p53, carcinoembryonic Ag, Her2/neu, and MAGE2/3 were screened for their capacity to induce CTLs, in vitro, capable of recognizing tumor target lines. All the peptides bound HLA-A*0201 and two or more additional A2 supertype alleles with an IC50 of 500 nM or less. A total of 20 of 22 wild-type and 9 of 12 single amino acid substitution analogues were found to be immunogenic in primary in vitro CTL induction assays, using normal PBMCs and GM-CSF/IL-4-induced dendritic cells. These results suggest that peripheral T cell tolerance does not prevent, in this system, induction of CTL responses against tumor-associated Ag peptides, and confirm that an HLA class I affinity of 500 nM or less is associated with CTL epitope immunogenicity. CTLs generated by 13 of 20 of the wild-type epitopes, 6 of 9 of the single, and 2 of 5 of the double substitution analogues tested recognized epitopes generated by endogenous processing of tumor-associated Ags and expressed by HLA-matched cancer cell lines. Further analysis revealed that recognition of naturally processed Ag was correlated with high HLA-A2.1-binding affinity (IC50 = 200 nM or less; p = 0.008), suggesting that high binding affinity epitopes are frequently generated and can be recognized as a result of natural Ag processing. These results have implications for the development of cancer vaccines, in particular, and for the process of epitope selection in general.
Lymphoid Neogenesis in Rheumatoid Synovitis
Takemura, Seisuke, Braun, Andrea , Crowson, Cynthia S. , Kurtin, Paul J. , Cofield, Robert H. , O’Fallon, W. Michael, Weyand, Cornelia M. , Goronzy, Jörg J.

The Journal of Immunology | April 21, 2014 | Volume: 167 | Issue: 2 | Pages: 1072-1080

10.4049/jimmunol.167.2.1072 | PMID 11441118 Get It

Abstract In rheumatoid arthritis (RA), tissue-infiltrating lymphocytes can be arranged in sophisticated organizations that resemble microstructures usually formed in secondary lymphoid organs. Molecular pathways and host risk factors involved in this process of lymphoid neogenesis remain to be defined. In a series of 64 synovial tissue biopsies, lymphoid follicles with germinal centers (GCs) were found in 23.4% of the patients. Follicular dendritic cells (FDCs) were exclusively present in tissues with GCs, suggesting that the recruitment or in situ maturation of FDCs is a critical factor for GC formation in the synovial membrane. Primary follicles were absent, emphasizing the role of Ag recognition in the generation of inflammation-associated lymphoid organogenesis. Multivariate logistic regression analysis of tissue cytokines and chemokines identified two parameters, in situ transcription of lymphotoxin (LT)-β and of B lymphocyte chemoattractant (BLC; BLC/CXCL13), that were predictors for FDC recruitment and synovial GC formation. LT-β and BLC/CXCL13 were found to be independent variables that could, in part, compensate for each other to facilitate GC formation. Prediction models incorporating in situ transcription of LT-β and BLC/CXCL13 had high negative yet moderate positive predictive values, suggesting that LT-β and BLC/CXCL13 are necessary but not sufficient. LT-β protein was detected on a subset of mantle zone and GC B cells, but also on T cells in follicular structures. BLC/CXCL13 was produced by FDCs in follicular centers, but was predominantly found in endothelial cells and synovial fibroblasts, suggesting heterotypic signaling between cells of the synovial membrane and infiltrating lymphocytes in regulating extranodal lymphoid neogenesis.
LIGHT, a TNF-Like Molecule, Costimulates T Cell Proliferation and Is Required for Dendritic Cell-Mediated Allogeneic T Cell Response
Tamada, Koji , Shimozaki, Koji , Chapoval, Andrei I. , Su, Jeffery, Chen, Su-Fang, Nagata, Shigekazu , Zhai, Yifan , Hsieh, Shie-Liang Edmond , Ni, Jian , Chen, Lieping

The Journal of Immunology | April 21, 2014 | Volume: 164 | Issue: 8 | Pages: 4105-4110

10.4049/jimmunol.164.8.4105 | PMID 10754304 Get It

Abstract LIGHT is a recently identified member of the TNF superfamily and its receptors, herpesvirus entry mediator and lymphotoxin β receptor, are found in T cells and stromal cells. In this study, we demonstrate that LIGHT is selectively expressed on immature dendritic cells (DCs) generated from human PBMCs. In contrast, LIGHT is not detectable in DCs either freshly isolated from PBMCs or rendered mature in vitro by LPS treatment. Blockade of LIGHT by its soluble receptors, lymphotoxin β receptor-Ig or HVEM-Ig, inhibits the induction of DC-mediated primary allogeneic T cell response. Furthermore, engagement of LIGHT costimulates human T cell proliferation, amplifies the NF-κB signaling pathway, and preferentially induces the production of IFN-γ, but not IL-4, in the presence of an antigenic signal. Our results suggest that LIGHT is a costimulatory molecule involved in DC-mediated cellular immune responses.
Response to Letter Regarding Article, “Rosiglitazone and Outcomes for Patients With Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial”
Bach, Richard G. , Brooks, Maria M. , Lombardero, M. , Genuth, Saul, Donner, Thomas , Garber, Alan J., Kennedy, Laurence, Monrad, E. Scott, Pop‐Busui, Rodica , Kelsey, Sheryl F., Frye, Robert L. , Pop-Busui, Rodica

Circulation | April 21, 2014 | Volume: 129 | Issue: 16 | Pages: No page available

10.1161/circulationaha.113.008033 | PMID 24753557 Get It

Prevention of Spontaneous Breast Carcinoma by Prophylactic Vaccination with Dendritic/Tumor Fusion Cells
Xia, Jian‐Chuan , Mukherjee, Pinku , Gendler, Sandra , Tanaka, Yasuhiro , Koido, Shigeo , Liu, Chunlei , Gong, Jianlin

The Journal of Immunology | April 21, 2014 | Volume: 170 | Issue: 4 | Pages: 1980-1986

10.4049/jimmunol.170.4.1980 | PMID 12574367 Get It

Abstract Genetically modified mice with spontaneous development of mammary carcinoma provide a powerful tool to study the efficacy of tumor vaccines, since they mimic breast cancer development in humans. We used a transgenic murine model expressing polyomavirus middle T oncogene and mucin 1 tumor-associated Ag to determine the preventive effect of a dendritic/tumor fusion cell vaccine. The MMT (a transgenic murine model) mice developed mammary carcinoma between the ages of 65–108 days with 100% penetrance. No spontaneous CTL were detected. However, prophylactic vaccination of MMT mice with dendritic/tumor fusion cells induced polyclonal CTL activity against spontaneous mammary carcinoma cells and rendered 57–61% of the mice free of the disease at the end of experiment (180 days). Furthermore, the level of CTL activity was maintained with multiple vaccinations. The antitumor immunity induced by vaccination with dendritic/tumor fusion cells reacted differently to injected tumor cells and autochthonous tumor. Whereas the injected tumor cells were rejected, the autochthonous tumor evaded the attack and was allowed to grow. Collectively these results indicate that prophylactic vaccination with dendritic/tumor fusion cells confers sufficient antitumor immunity to counter the tumorigenesis of potent oncogenic products. The findings in the present study are highly relevant to cancers in humans.
Naturally Occurring Human IgM Antibody That Binds B7-DC and Potentiates T Cell Stimulation by Dendritic Cells
Radhakrishnan, Suresh , Nguyen, Loc T. , Ćirić, Bogoljub , Ure, Daren , Zhou, Bin , Tamada, Koji , Tseng, Su-Yi, Shin, Tahiro, Pardoll, Drew M. , Kyle, Robert A. , Pease, Larry R. , Dong, Haidong , Chen, Lieping , Rodriguez, Moses

The Journal of Immunology | April 21, 2014 | Volume: 170 | Issue: 4 | Pages: 1830-1838

10.4049/jimmunol.170.4.1830 | PMID 12574348 Get It

Abstract A human IgM Ab, serum-derived human IgM 12 (sHIgM12), is identified that binds mouse and human dendritic cells (DC), inducing dramatic immunopotentiation following treatment of the mouse DC in vitro. Competition, transfection, and knockout studies identified the ligand on mouse DC as the costimulatory molecule family member B7-DC. Potent T cell responses are stimulated by Ag-pulsed DC treated with the sHIgM12 Ab in vitro and upon adoptive transfer of Ab-treated Ag-pulsed DC into animals. The multivalent structure of pentameric IgM provides the potential for cross-linking cell surface targets, endowing the soluble Abs with biological potential not normally associated with immune function. The ability of the sHIgM12 Ab to potentiate the immune response is dependent on the multimeric structure of IgM, as bivalent monomers do not retain this property. Furthermore, pretreatment of DC with IgM monomers blocks subsequent potentiation by intact IgM pentamers, an indication that cross-linking of B7-DC on the cell surface is critical for potentiation of Ag presentation. These findings imply that, in addition to known costimulatory roles, B7-DC can function as a receptor for signals delivered by cells expressing B7-DC ligands.
ExpandedC9ORF72Hexanucleotide Repeat in Depressive Pseudodementia
Bieniek, Kevin F. , Blitterswijk, Marka van , Petrucelli, Leonard , Rademakers, Rosa , Dickson, Dennis W. , van Blitterswijk, Marka, Baker, Matthew C, Baker, Matthew , van Blitterswijk, Marka , Dickson, Dennis W

JAMA Neurology | April 21, 2014 | Volume: 71 | Issue: 6 | Pages: 775

10.1001/jamaneurol.2013.6368 | PMID 24756204 Get It

Quality and Safety of Minimally Invasive Surgery: Past, Present, and Future
LaGrange, Chad A. , Hallbeck, Ms, McCrory, Bernadette , Hallbeck, M. Susan

Biomedical Engineering and Computational Biology | April 21, 2014 | Volume: 6 | Issue: No issue available | Pages: No page available

10.4137/becb.s10967 | PMID 25288906 Get It

Adverse events because of medical errors are a leading cause of death in the United States (US) exceeding the mortality rates of motor vehicle accidents, breast cancer, and AIDS. Improvements can and should be made to reduce the rates of preventable surgical errors because they account for nearly half of all adverse events within hospitals. Although minimally invasive surgery (MIS) has proven patient benefits such as reduced postoperative pain and hospital stay, its operative environment imposes substantial physical and cognitive strain on the surgeon increasing the risk of error. To mitigate errors and protect patients, a multidisciplinary approach is needed to improve MIS. Clinical human factors, and biomedical engineering principles and methodologies can be used to develop and assess laparoscopic surgery instrumentation, practices, and procedures. First, the foundational understanding and the imperative to transform health care into a high-quality and safe system is discussed. Next, a generalized perspective is presented on the impact of the design and redesign of surgical technologies and processes on human performance. Finally, the future of this field and the research needed to further improve the quality and safety of MIS is discussed.